Loading provider…
Loading provider…
Surgery Physician in San Antonio, TX
NPI: 1043538168Primary Practice Location
UNIVERSITY HEALTH SYSTEM
4502 Medical Dr, San Antonio, TX
Primary Employer
UT Health Physicians
uthscsa.edu
HQ Phone
Get MD Christopher's Phone Numberphone_androidMobile
Get MD Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2015 - 2026

American Board of Surgery
Surgery

American Board of Surgery
Surgical Critical Care
University of Arkansas for Medical Sciences (UAMS) College of Medicine
Residency • Surgery
2010 - 2012
University of Arkansas For Medical Sciences College of Medicine
Medical School
Until 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 14 | 14 |
Authors: Crane, Christopher, Akhter, Noor, Johnson, Brandy W, Iruthayanathan, Mary, Syed, Farhan, Kudo, Akihiko, Zhou, Yi-Hong, Childs, Gwen V
Journal: J Histochem Cytochem
Publication Date: 2007-06-26
Authors: Sharmila Dissanaike, Cressilee Bryant, Brandon Bruns, Daniel Margulies, Elizabeth Scherer, Adel Alhaj Saleh, Justin Regner, Jeremy Ward, Richard Frazee, Eric Campion, Thomas Schroeppel, Galinos Barmparas, Matthew Bartley
Journal: Trauma Surg Acute Care Open
Publication Date: 2021-05-19
Ghrelin Restoration of Function In Vitro in Somatotropes from Male Mice Lacking
Authors: Syed, Mohsin, Cozart, Michael, Haney, Anessa C, Akhter, Noor, Odle, Angela K, Allensworth-James, Melody, Crane, Christopher, Syed, Farhan M, Childs, Gwen V
Journal: Endocrinology
Publication Date: 2013-02-15
Lead Sponsor: Atox Bio Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Reltecimod 0.5 mg/kg
Lead Sponsor: Atox Bio Ltd
Collaborators: Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: AB103 0.5 mg/kg, OTHER: NaCl 0.9%